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The aim of this work was to evaluate the effects of therapeutic doses of Cimicifuga racemosa on
cardiovascular parameters and on liver lipid metabolism and redox status in an animal model of
estrogen deﬁciency associated with hypertension, a condition that could make the liver more
vulnerable to drug-induced injuries. Female Wistar rats were subjected to the surgical procedures of
bilateral ovariectomy (OVX) and induction of renovascular hypertension (two-kidneys, one-clip; 2K1C).
These animals (OVX þ 2K1C) were treated with daily doses of a C. racemosa extract, using a dose that is
similar to that recommended to postmenopausal women (0.6 mg/kg), over a period of 15 days. The
results were compared to those of untreated OVX þ 2K1C, OVX, and control rats. The treatment with C.
racemosa caused a signiﬁcant reduction in blood pressure. In the liver, treatment did not prevent the
development of steatosis, and it reduced the mitochondrial and peroxisomal capacity to oxidize
octanoyl-CoA compared to the untreated animals. In addition, C. racemosa caused numerous undesir-
able effects on the liver redox status: it increased the mitochondrial reactive oxygen species generation,
an event that was not accompanied by an increase in the activity of superoxide dismutase, and it
induced a decrease in peroxisomal catalase activity. Although the reduced glutathione content had not
been affected, a phenomenon that probably reﬂected the restoration of glucose-6-phosphate dehy-
drogenase activity by C. racemosa, oxidative damage was evidenced by the elevated level of
thiobarbituric acid-reactive substances found in the liver of treated animals.
& 2012 Elsevier Inc. Open access under the Elsevier OA license.Indroduction
Estrogen deﬁciency triggers several disorders in lipid metabo-
lism that lead to a higher incidence of metabolic syndrome and its
comorbidities. Therefore, hypertension is the most frequent dis-
ease associated with the postmenopausal period [1,2]. In addition,
estrogen deﬁciency directly contributes to development of hyper-
tension by mechanisms that include the overproduction of3
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lsevier OA license.vasoconstrictor factors such as endothelin [3], hyperactivity of
the sympathetic nervous system and renin–angiotensin system
(RAS)1, insulin resistance, increased levels of inﬂammatory mar-
kers, and oxidative stress [4,5].
Cimicifuga racemosa, or black cohosh, is a plant used in the
treatment of menopausal symptoms, especially for reducing hot
ﬂushes [6,7]. Phytochemical studies have revealed that certain
constituents of C. racemosa stand out, including triterpene glyco-
sides, phenolic constituents [8], and formonectin (an isoﬂa-
vone) [9]. Ethanolic and isopropanolic dried extracts of roots
and rhizomes of this plant are currently available to consumers in
a range of formulations and dosages although there is no agree-
ment about its beneﬁcial effects on menopausal symptoms
[8–10].
Studies concerning the safety of C. racemosa have also been
performed, and although this plant is considered safe for use by
women experiencing menopausal symptoms [11], there have
been recent reports of undesirable hepatic events associated with
ingestion of C. racemosa [12,13]. Lu¨de et al. [14] performed a
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involved in vivo and in vitro experiments. This study revealed that
female Wistar rats treated with daily, high doses of C. racemosa
(1000mg/kg) developed microvesicular steatosis, probably as a result
of an inhibition of mitochondrial fatty acid b-oxidation, demonstrated
by in vitro experiments. The authors concluded that microvesicular
steatosis of these animals, which had been observed only with toxic
concentrations of C. racemosa, should not be considered clinically
relevant for most patients but may become important for patients
with underlying risk factors [14].
Therefore, in agreement with the rationale of Lu¨de et al. [14],
we considered an evaluation of the hepatotoxicity of C. racemosa
in an animal model of estrogen deﬁciency associated with
renovascular hypertension to be necessary. Estrogen deﬁciency
is associated with a higher incidence of hepatic steatosis [15] and
both are associated with oxidative stress [4,16]. This, in turn,
could make the liver more susceptible to the undesirable effects
of C. racemosa in reducing the liver fatty acid disposal.
Ovariectomized (OVX) rats are well-established models of
estrogen deﬁciency and were used in this study. The induction
of hypertension was achieved by applying a clip around the left
renal artery (two-kidneys, one-clip; 2K1C), as described by
Goldblatt et al. [17]. This renovascular hypertension is character-
ized by RAS hyperactivity, which is also frequently involved in
postmenopausal hypertension [1].
Therefore, we believe that the treatment of these animals with
daily doses of C. racemosa, similar to those recommended for
women in the postmenopausal period, will allow an evaluation of
the effects of the treatment of hypertensive postmenopausal
women with C. racemosa on liver lipid metabolism and redox
status.Materials and methods
Materials
The apparatus for mitochondrial incubation was built in the
workshops of the University of Maringa´. The substrates, ADP,
phenylmethylsulfonyl ﬂuoride, o-phthalaldehyde (OPT), horse-
radish peroxidase, 20,70-dichloroﬂuorescein diacetate (DCFH-DA),
20,70-dichloroﬂuorescein (DCF), 2,4-dinitrophenol (DNP), and
urethane were purchased from Sigma Chemical Co. (St. Louis,
MO, USA). Pentobarbital (Hypnol) was from Crista´lia Produtos
Quı´micos e Farmaceˆuticos Ltda (S~ao Paulo, Brazil). Kits from Gold
Analisa were used for plasma dosages. Dried fruit of C. racemosa
was obtained from Deg. All other reagents were obtained at the
highest available grade.
Animals
Batches of female Wistar rats (8 weeks of age) were randomly
designated for surgical procedure of sham operation (control),
bilateral ovariectomy (OVX), or ovariectomy plus renovascular
hypertension (OVX þ 2K1C). The rats had free access to tap water
and a standard laboratory diet (Nuvilab, S~ao Paulo, Brazil). The
food consumption and animal weights were measured through-
out the entire experimental period (36 days). All experiments
were conducted in strict adherence to the guidelines of the Ethics
Committee for Animal Experimentation of the University of
Maringa´ (Certiﬁcate No. 050/2011).
Surgical procedures
For the surgical procedures, the animals were anesthetized
with a mixture of xylazine and ketamine (10 and 50 mg/kg ip).A single 15-mm peritoneal incision was made to perform both the
removal of the ovaries and the induction of renovascular hyper-
tension. Renovascular hypertension was induced via the reduc-
tion of the renal blood ﬂow by constricting the left renal artery
with a silver clip (internal diameter of 0.2 mm), following the
Goldblatt 2K1C model [17]. Sham-operated (control) rats under-
went the same surgical procedure but clipping of the renal artery
and removal of the ovaries were omitted.
Animal treatment
Twenty-one days after the surgical procedures, the OVX þ
2K1C group was randomly subdivided into two groups: untreated
rats (OVX þ 2K1C) and animals treated with daily doses of C.
racemosa extract of 0.6 mg/kg body wt (OVX þ 2K1CT) This
dosage is similar to those recommended to postmenopausal
women (40 mg/day, considering a woman weighing 60 kg). The
extract of dried roots of C. racemosa was administered by oral
gavage over 15 days as a suspension in an aqueous solution of
1.0% gum arabic. Controls were conducted to provide similar daily
volumes of gum arabic (vehicle) to the sham-operated (control),
OVX, and OVX þ 2K1C rats. Thirty-six days after the surgical
procedure, the rats that had fasted overnight were anesthetized to
insert a cannula into the carotid artery, for the direct measure-
ment of mean arterial pressure (MAP) and blood collection, and
the subsequent removal of the liver and adipose tissues.
General features
The amount of food intake was measured three times a week,
and the animal body weight was measured weekly. The retro-
peritoneal, uterine, mesenteric, and inguinal fats were collected
and the ratio between the sums of the weights of these tissues per
100 g of body weight was deﬁned as the adiposity index.
Mean arterial pressure measurements and plasma biochemical
analysis
The female rats were anesthetized with a combination of
pentobarbital and urethane (50 and 600 mg/kg ip). A polyethy-
lene cannula was inserted into the carotid artery and connected
to a mercury manometer for the direct measurement of the MAP.
The same cannula that was inserted into the carotid artery was
used to collect blood for biochemical analysis.
Uterine atrophy was used as a marker for a well-established
condition of estrogen deﬁciency, and the observation of atrophy
of the left kidney and hypertrophy of the right kidney was used to
evaluate the success of the hypertension induction surgery. Only
data for animals that showed reduced weight of the left kidney
were used in the experiments. The ratio between the weight of
the right and the left kidneys was calculated by sampling batches
of animals. Whereas control and OVX rats had ratios close to 1.0
(0.9970.03, n¼9, and 0.9970.05, n¼6, respectively), OVX þ
2K1C rats had a ratio that increased to 3.1570.53 (n¼6) and that
did not differ signiﬁcantly from that of the OVX þ 2K1CT rats
(2.7470.67, n¼6).
Total cholesterol, HDL-cholesterol, triacylglycerols (TGs),
fasted plasma glucose, aspartate aminotransferase (AST), and
alanine aminotransferase (ALT) were analyzed by standard meth-
ods (Gold Analisa). The level of VLDL-cholesterol was calculated
using Friedewald’s equation, and the level of LDL-cholesterol was
determined by subtracting HDL and VLDL from total cholesterol.
The fasting plasma insulin dosages were performed by radio-
immunoassay. Insulin resistance was measured in terms of the
homeostasis model assessment (HOMA) index [18] using the
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HOMA index¼ fasting plasma insulinðmU=LÞ
½fasting plasma glucose ðmmol=LÞ=22:5:
Liver histochemical analysis and determination of the total lipid
content
Fragments of the liver were processed and stained with Sudan III,
which speciﬁcally detects lipids. The total lipid content of the liver
was measured by gravimetry [19] and expressed in grams per 100 g
of liver (wet weight).
Isolation of rat liver mitochondria and peroxisomes
Rat liver mitochondria were isolated as described by Bracht
et al. [20] and peroxisomes were isolated according to the method
described by Natarajan et al. [21]. Both techniques are based on
the homogenization of the liver (using a Dounce homogenizer) in
a medium containing sucrose–mannitol and the subsequent
isolation of the subcellular fraction by differential centrifugation
[20,21]. Protein concentrations were determined according to
the method of Lowry et al. using bovine serum albumin as a
standard [22].
Oxygen uptake by mitochondria oxidizing fatty acids
Oxygen uptake by intact mitochondria oxidizing fatty acids
was determined polarographically using a Clark-type oxygen
electrode (Yellow Springs Instruments, Yellow Springs, OH,
USA). Mitochondria (0.6–1.2 mg/ml) were incubated at 37 1C in
2 ml (ﬁnal volume) of a speciﬁc incubation medium [23]. The
b-oxidation capacity was assayed in the presence of 100 mM DNP.
The reactions were initiated by the addition of (a) 20 mM octa-
noyl-CoA þ 2.0 mM L-carnitine, (b) 20 mM palmitoyl-CoA þ
2.0 mM L-carnitine, or (c) 20 mM palmitoyl-L-carnitine. The rate
of oxygen consumption was expressed as nmol/min  mg of
mitochondrial protein.
Peroxisomal fatty acyl-CoA oxidase and catalase (CAT) activities
The peroxisomal fatty acyl-CoA oxidase activities were mea-
sured ﬂuorimetrically using a modiﬁcation of the method
described by Small et al. [24,25]. The assay was based on the
determination of H2O2 production in a reaction catalyzed by
exogenous peroxidase, which was coupled to the oxidation of
DCFH-DA into the highly ﬂuorescent compound DCF. The enzyme
activity was monitored in real time by recording the variation in
ﬂuorescence. After the addition of the peroxisome-enriched frac-
tion (0.3 mg protein/ml), the reaction was initiated with the
addition of the substrate, octanoyl-CoA or palmitoyl-CoA (ﬁnal
concentration of 30 mM). The increase in ﬂuorescence (excitation,
503 nm; emission, 529 nm) was recorded over a period of 10 min,
and the activity of fatty acid acyl-CoA oxidase was expressed as
pmol DCF produced/min  mg of peroxisomal protein. The
peroxisomal CAT activity was measured according to the method
described by Aebi [26] and was expressed as mmol H2O2 reduced/
min  mg of protein.
Mitochondrial reactive oxygen species (ROS) generation
The mitochondrial ROS generation was monitored by the
oxidation of DCFH-DA into the ﬂuorescent compound DCF in the
presence of hydrogen peroxide. Mitochondria (1 mg protein/ml)
were preincubated with 5 mM each glutamate and malate and15 mMDCFH-DA. After 3 min, 600 mmol/L ADP was added, and the
ﬂuorescence was recorded for 5 min (excitation, 503 nm; emis-
sion, 529 nm). The mitochondrial ROS generation was expressed
as pmol DCF produced/min  mg of mitochondrial protein [27].
Redox state evaluation
Liver fragments were freeze-clamped in liquid nitrogen and
homogenized with a Van-Potter homogenizer for the evaluation
of reduced glutathione (GSH) and thiobarbituric acid-reactive
substances (TBARS). The GSH levels were determined ﬂuorime-
trically (excitation, 350 nm; emission, 420 nm) in the superna-
tant, using OPT according to the method described by Hissin
and Hilf [28]. The results were deﬁned as the index of oxidative
stress and expressed as mg GSH/mg of protein present in the
supernatant.
Liver TBARS concentrations were measured by direct spectro-
photometry and were used as biomarkers of lipid peroxidation
and oxidative stress [29]. The results were expressed as nmol
malondialdehyde (MDA)/mg protein using a molar extinction
coefﬁcient for MDA of 1.56  105 M1 cm1.
The activities of the following antioxidant enzymes were
measured in supernatants obtained by centrifuging liver homo-
genates at 15,000g: glutathione reductase (GSSG-red) [30], glu-
tathione peroxidase (GSH-Px) [31], superoxide dismutase (SOD)
[32], and glucose-6-phosphate dehydrogenase (G6PD) [33].
Treatment of data
The data in the ﬁgures and tables are presented as mean-
s7standard error of the mean (SEM). The data were analyzed
using Student’s t test or analysis of variance (ANOVA). The
compared values are provided in the text as probability values
(p), and the minimum criterion of signiﬁcance was p r 0.05.
Statistical analyses were performed with the Prism GraphPad
5.0 software (GraphPad Software, Inc.).Results
General features
Fig. 1 shows the gain of weight of the four animal groups
studied, from the day of the surgical ovariectomy or induction of
hypertension until the end of the experimental period (36 days).
The results, presented as area under the curve (AUC), revealed
that the control groups exhibited weight gains of approximately
37%. In contrast, OVX, OVX þ 2K1C, and OVX þ 2K1CT rats
exhibited signiﬁcantly higher weight gains of approximately 45%
(the values for the three groups of animals were not signiﬁcantly
different). However, as shown in Table 1, only the OVX and OVX
þ 2K1CT rats had increases in weight accompanied by increases
in adiposity (þ29 and þ35.5% for the OVX and OVX þ 2K1CT
rats, respectively). In addition, as shown in Table 1, these altera-
tions in adiposity and weight gain occurred in the absence of
alterations in food intake.
Mean arterial pressure measurements and plasma biochemical
analyses
The cardiovascular parameters for the various groups of rats
are presented in Table 2. The MAP of OVX rats did not differ
signiﬁcantly from that of the control rats. As expected, the OVX þ
2K1C rats presented signiﬁcantly increased MAP values (þ28%)
compared to OVX and control rats (po0.001). This effect was
partially but signiﬁcantly reversed for approximately 9% of the
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OVX þ 2K1CT rats, the MAP values remained signiﬁcantly higher
than those of the controls and the OVX rats.
No differences were observed in the glycemia or insulinemia of
these animal groups. In addition, the peripheral insulin sensitivity
was not altered in these animals, as demonstrated by the HOMA
index. The assessment of the lipid proﬁle of these animals
revealed that the serum levels of TGs, the total cholesterol, and
the HDL-, LDL-, and VLDL-cholesterol did not differ signiﬁcantly in0
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Fig. 1. Body weight gain. The body weights of sham-operated (control), bilateral
ovariectomized (OVX), and OVX þ 2K1C untreated (OVX þ 2K1C) and C.
racemosa-treated (OVX þ 2K1CT) rats, measured during the 36 days from the
surgical procedures until the end of the treatment are shown. The results
represent the means of the AUC, calculated by subtracting the weight at the
beginning of the treatment of 7 to 10 animals. Vertical bars represent the standard
errors. npo0.05; signiﬁcant difference between the values as revealed by ANOVA.
Table 1
General features.
Control OVX
Adiposity indexa 3.9170.29 5.047
Food consumptionb 19.3970.71 21.077
a The adiposity index is represented by the ratio between the sum of the weights of th
expressed as the mean7SEM.
b Food consumption (g/day; n¼4) is expressed as the mean7SEM.
n po0.05 vs the control.
Table 2
Cardiovascular parameters.
Control OVX
Mean arterial pressure 100.9073.13 103.90
Glycemia 93.3373.27 87.89
Insulinemia 0.3970.03 0.52
HOMA index 2.1770.11 2.83
Triacylglycerols 41.9871.54 46.23
Total cholesterol 75.3472.81 75.73
HDL 55.2273.99 47.68
LDL 12.3371.47 15.04
VLDL 8.0670.37 8.67
AST 108.0076.29 118.90
ALT 30.8172.30 34.88
The mean arterial pressure (mm Hg; n¼20–25), glycemia (mg/dl; n¼7–8), insulinemi
cholesterol (mg/dl; n¼8–12), high-density lipoprotein (HDL; mg/dl; n¼8–10), low-den
n¼10–12), aspartate aminotransferase (AST; mg/dl; n¼12–15), and alanine aminotrans
same line shows the statistical signiﬁcance of the values calculated by ANOVA.
# po0.001 vs the control and OVX.
nn po0.01 vs OVX þ 2K1C.the four animal groups. The AST and ALT plasma dosages, used as
indices for hepatic injury, did not differ in these animal groups.
Liver histochemical analysis and the determination of the total lipid
content
The liver histological sections of the control (image a), OVX
(image b), OVX þ 2K1C (image c), and OVX þ 2K1CT (image d)
rats stained with Sudan III are presented in Fig. 2. In contrast to
the control rats, livers from OVX, OVX þ 2K1C, and OVX þ 2K1CT
rats contained considerable amounts of lipid inclusions (in
orange, Fig. 2). These results were corroborated by a second series
of experiments in which the total lipid content of the liver was
assessed by gravimetry. The results are presented in Fig. 3.
Whereas livers from female control rats had a normal total lipid
content of approximately 5% [34], OVX, OVX þ 2K1C, and OVX þ
2K1CT rats had signiﬁcantly higher lipid contents (þ26.4, þ21.6,
and þ36.1%, respectively).
Fatty acid oxidation by liver mitochondria
Fig. 4 shows the mitochondrial b-oxidation of octanoate and
palmitate. These fatty acids were utilized as acyl-CoA derivatives
in the presence of L-carnitine. In another series of experiments,
palmitoyl-L-carnitine was used. The b-oxidation capacity was
determined in the presence of 100 mM DNP. Under these condi-
tions, no differences were observed in the oxidation of octanoyl-
CoA by mitochondria from OVX and OVX þ 2K1C rats compared
to the control rats. For the OVX þ 2K1CT rats, the oxidation of
octanoyl-CoA, which was similar to the oxidation activity of the
control groups, was signiﬁcantly reduced to approximately 23%
compared to the OVX and OVX þ 2K1C groups (po0.05).OVX þ 2K1C OVX þ 2K1CT
0.32n 4.6670.33 5.3070.48n
0.84 18.2670.72 20.4271.01
e retroperitoneal, uterine, mesenteric, and inguinal fats (g/100 g body wt; n¼5 or 6),
OVX þ 2K1C OVX þ 2K1CT
71.53 129.0072.90# 117.8072.33#,nn
73.75 85.3274.05 85.9974.76
70.06 0.4470.05 0.4770.05
70.29 2.2370.29 2.5970.34
71.54 43.4871.90 45.7672.70
72.78 80.2972.52 83.9973.45
72.34 48.0473.67 54.1274.26
71.53 12.2871.72 12.7972.07
70.33 8.3270.32 9.15 7 0.54
72.35 114.4075.79 117.5076.47
71.20 28.7772.80 31.8871.69
a (ng/dl; n¼5–7), HOMA index (n¼5–6), triacylglycerols (mg/dl; n¼10–14), total
sity lipoprotein (LDL; mg/dl; n¼7–9), very low density lipoprotein (VLDL; mg/dl;
ferase (ALT; mg/dl; n¼5–13) are expressed as the mean7SEM. The symbol in the
Fig. 2. Liver histochemical analyses. Liver slices were frozen at 80 1C, sectioned with a cryostat, and stained for lipids using Sudan III. The images were captured at
40 original magniﬁcation. In contrast to the control (sham-operated, image a), livers from OVX (image b), OVX þ 2K1C (image c), and OVX þ 2K1CT (image d) rats
contained considerable amounts of lipid inclusions (orange) as indicated by the arrows.
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Fig. 3. Total liver lipid content determined by gravimetry. Liver fragments
(approximately 1.0 g) were homogenized in a 2:1 mixture of chloroform and
methanol to determine the total lipid content. The total liver lipid content is
expressed as grams/100 g of liver (wet wt), and the values are the means of 4 to
6 individual analyses. The vertical bars represent the standard errors. npo0.05;
nnpo0.01; signiﬁcant difference between the values as revealed by ANOVA.
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Fig. 4. Determination of the oxygen consumption by mitochondria performing
fatty acid oxidation. Liver mitochondrial fatty acid b-oxidation was measured by
polarography in the presence of 100 mM DNP. Reactions were initiated by the
addition of the following: 20 mM octanoyl-CoA þ 2.0 mM L-carnitine (Oct-CoA),
20 mM palmitoyl-CoA þ 2.0 mM L-carnitine (Palm-CoA), or 20 mM palmitoyl-L-
carnitine (Palm-L-Car). Mitochondria (0.6–1.0 mg/ml) were incubated in a ﬁnal
volume of 2.0 ml. Values are expressed as the means of 8 to 14 individual
experiments with different mitochondrial preparations. The vertical bars repre-
sent the standard errors. npo0.05; signiﬁcant difference between the values as
revealed by ANOVA.
L.B. Campos et al. / Free Radical Biology and Medicine 53 (2012) 680–689684With respect to palmitate, the mitochondrial b-oxidation
capacity did not differ among these four animal groups whether
the substrate was presented as the palmitoyl-CoA derivative in
the presence of carnitine or as palmitoyl-L-carnitine.Peroxisomal fatty acyl-CoA oxidases and CAT activities
In contrast to mitochondria, the peroxisomal fatty acid
b-oxidation system is not associated with a phosphorylating
system and, in the rat liver, is responsible for the generation of
approximately 35% of all H2O2 formed [35], accounting for
approximately 20% of the total oxygen consumption [36]. To
maintain the equilibrium between the production and the scaven-
ging of ROS, peroxisomes concentrate the bulk of the cellular CAT
activity [37]. Conditions under which the peroxisomal b-oxida-
tion is disproportionally increased compared to the CAT activity
are associated with oxidative stress. Fig. 5 presents the perox-
isomal fatty acid b-oxidation activity (Fig. 5A) and the peroxiso-
mal CAT activity (Fig. 5B).Analysis of the peroxisomal b-oxidation activity revealed that
octanoyl-CoA oxidation was decreased to approximately 26% in
the OVX rats, whereas it was unaffected in the OVX þ 2K1C rats
compared to the control group. The treatment of the animals with
C. racemosa resulted in a 21% decrease in the activity of octanoyl-
CoA oxidation compared to the OVX þ 2K1C rats (po0.05), but it
did not differ from the control and OVX groups.
When palmitoyl-CoA was used as a substrate, only the OVX
rats had a signiﬁcantly different activity for oxidizing this long-
chain fatty acid compared to the control rats because the activity
had decreased by approximately 31%.
Fig. 5B shows the CAT activities measured in liver peroxi-
somes. Compared to control rats, the activity of this enzyme was
signiﬁcantly diminished in the OVX, OVX þ 2K1C, and OVX þ
2K1CT groups (po0.001). In contrast, similar to the peroxisomal
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Fig. 5. Peroxisomal (A) b-oxidation and (B) catalase activity. The peroxisomal fatty
acyl-CoA oxidase activity was measured by ﬂuorimetry (excitation at 503 nm and
emission at 529 nm). This assay was based on an exogenous peroxidase-catalyzed
reaction between DCFH-DA and H2O2, which resulted in the formation of a
ﬂuorescent compound. The activity of fatty acid acyl-CoA oxidation is expressed
as pmol DCF produced/min  mg of protein. The reactions were initiated by the
addition of 30 mM octanoyl-CoA (Oct-CoA) or 30 mM palmitoyl-CoA (Palm-CoA).
The peroxisomal catalase activity was measured spectrophotometrically at
240 nm. The results are expressed as mmol H2O2 reduced/min  mg protein,
and the values are represented as the means of 7 to 11 experiments with different
peroxisomal preparations. The vertical bars represent the standard errors.
npo0.05; nnpo0.01; nnnpo0.001; signiﬁcant difference between the values as
revealed by ANOVA.
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was increased by approximately 50% compared to OVX rats, was
signiﬁcant reduced by approximately 15% in the animals treated
with C. racemosa; however, these values remained higher than
those of the OVX rats.Liver redox state parameters
In Figs. 6A–F are presented the mitochondrial ROS generation
and the alterations observed in the liver glutathione systems of
these animals. Mitochondria are the main cellular sources of ROS
generation, so the alterations in the liver redox status could be a
result of alterations in mitochondrial ROS generation, a possibility
that was evaluated in this work, and the results are presented in
Fig. 6A. Although a progressive increment in the mitochondrial
ROS generation can be observed from control to OVX and OVX þ
2K1C rats, only between OVX þ 2K1C and control rats did these
values reach statistical signiﬁcance (po0.05). The treatment of
the rats with C. racemosa extracts further increased the ROS
generation by mitochondria, in such a way that, compared to
OVX þ 2K1C and control rats, these values were signiﬁcantly
higher by approximately 70 and 164%, respectively. Considering
these results, the GSH contents and the activities of four anti-
oxidant enzymes directly involved in the ROS-scavenging GSH
system were also evaluated. The GSH content (Fig. 6B) was
signiﬁcantly reduced (po0.001) to similar extents in the OVX,
OVX þ 2K1C, and OVX þ 2K1CT rats.
An evaluation of the enzymatic activity of cellular ROS systems
also led to interesting results. The activity of SOD, which serves as
a ﬁrst antioxidant defense in mitochondria by catalyzing the
dismutation of superoxide anions to hydrogen peroxide, was
signiﬁcantly increased to similar extents in all experimental
groups (po0.05) compared to the control rats (Fig. 6C). The
activity of GSH-Px, which is a major cytosolic H2O2 scavenger,
did not differ among these animals (Fig. 6D). The activity of G6PD
(Fig. 6E), which provides NADPH to restore the GSH content,
signiﬁcantly decreased in the OVX rats and decreased further in
the OVX þ 2K1C rats compared to the control rats; however, the
G6PD activity was restored in the OVX þ 2K1CT rats to levels*
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activity (Fig. 6F), however, was signiﬁcantly higher for all experi-
mental groups compared to the control rats.
The increased mitochondrial ROS generation was expected to
lead to lipid peroxidation. Thus, lipid peroxidation levels were
assessed in the livers from these animals by TBARS measure-
ments. As shown in Fig. 7, the liver TBARS contents did not differ
in the OVX and OVX þ 2K1C rats compared to the control rats.
However, the TBARS content was signiﬁcantly increased by
approximately 35% in the OVX þ 2K1CT animals compared to
all other groups, evidencing the establishment of a condition of
moderate oxidative stress.Discussion
The results of this work revealed that, despite the beneﬁcial
effect in reducing blood pressure, the treatment of hypertensive
OVX rats with therapeutic doses of C. racemosa impaired the
mitochondrial and peroxisomal capacity to oxidize the medium-
chain fatty acid octanoate. In addition, C. racemosa increased the
mitochondrial ROS generation, without affecting the liver GSH
contents, probably because of its beneﬁcial effects of increasing
the activity of G6PD, the major cytosolic provider of NADPH,
needed to restore the GSH system. However, the increased liver
TBARS contents revealed that some oxidative damage already
occurred in livers from treated animals.
The beneﬁcial effects of the treatment with C. racemosa in
reducing the mean arterial pressure in our model of hypertensive
OVX rats, which presented a normal lipid proﬁle and an unaltered
sensitivity to insulin, excluded the possibility that C. racemosa
inﬂuenced these parameters. Therefore, our results are consistent
with previous reports describing the absence of effects of C.
racemosa on the lipid proﬁle [38,39] or insulin resistance [40,41]
in postmenopausal women.
In addition, the effect of C. racemosa on the blood pressure
could not be attributed to reductions in body weight gain or
adiposity index associated with estrogen deprivation either.
Although there are reports that C. racemosa decreases food intake
and obesity [42,43], the inconsistency with our results could be
explained by differences in the animal model used.
Therefore, one possibility is that the decrease in blood pressure
induced by C. racemosa in our animal model could be the result of
a vasorelaxant effect that has been demonstrated in isolated rat
aortic rings using compounds isolated from Cimicifuga rizhome
[44] and C. racemosa extract [45]. In addition, the vasorelaxanteffects of C. racemosa could explain, at least in part, its efﬁcacy in
the treatment of menopausal symptoms, such as hot ﬂushes
[46,47], and for alleviating postmenopausal cardiovascular
diseases [45].
The evaluation of the liver lipid metabolism revealed that the
ovariectomy increased the amount of accumulated fat. The
association between estrogen deﬁciency and hepatic steatosis
has been recognized [15]. Estrogen controls the expression of
nuclear factors and plays a fundamental role in lipid metabolism
[48,49]. In a condition of estrogen deﬁciency, lipid metabolism is
diverted from fatty acid oxidation to FFA synthesis, thereby
favoring hepatic triglyceride accumulation [48,49]. Interestingly,
neither the creation of a hypertensive phenotype nor the treat-
ment with C. racemosa provoked further liver fat accumulation,
although a clear tendency to increase liver fat has been observed
in animals treated with C. racemosa.
Following this rationale and considering the ﬁndings of Lu¨de
et al. [14], which demonstrated that C. racemosa inhibited
mitochondrial b-oxidation and induced steatosis when used at
toxic concentrations, we investigated whether the effects of
C. racemosa on mitochondrial and peroxisomal b-oxidation were
manifested at therapeutic doses in this animal model. Interest-
ingly, different mechanisms appeared to be involved in the
b-oxidation responses in the organelles obtained from ovariect-
omy, hypertension induction, and C. racemosa treatment.
For example, the mitochondrial b-oxidation of octanoate was
not affected by ovariectomy or renovascular hypertension, but it
was reduced by the treatment with C. racemosa. In contrast, for
peroxisomes, the activities of b-oxidation of octanoate and
palmitate were reduced by ovariectomy, whereas the induction
of the hypertension returned these activities to levels that were
similar to those found in the control rats. The treatment with C.
racemosa signiﬁcantly impaired only the peroxisomal activity of
oxidizing the medium-chain fatty acid compared to the untreated,
hypertensive OVX rats.
The same response pattern was observed with the CAT activity,
which was reduced by the treatment with C. racemosa. This response
is expected because the main function of peroxisomal CAT is the
decomposition of H2O2 generated by various peroxisomal oxidases,
and the expression of CAT is controlled by cellular H2O2 concentra-
tions [35]. Therefore, the minor peroxisomal b-oxidation accompa-
nied by a reduced CAT activity makes sense. However, the discovery
of several ROS-metabolizing enzymes in peroxisomes supports the
notion that these ubiquitous organelles play a crucial role in both the
production and the scavenging of ROS in the cell, in particular the
scavenging of H2O2 [50].
In summary, the results of this work point to two negative
consequences of the inhibitory action of C. racemosa on CAT
activity. First, the activity of this enzyme seems to be dispropor-
tionally reduced compared to peroxisomal b-oxidation because
the oxidation of the long-chain palmitate was unaffected by
treatment with C. racemosa. This reduced activity can disrupt
the balance between peroxisomal ROS generation and ROS
scavenging. Second, the reduced CAT activity might result in
oxidative damage to the entire cell.
The measurement of mitochondrial ROS generation led to
interesting results in this study. The mitochondrial ROS genera-
tion was increased in the OVX and OVX þ 2K1C rats, which was
not surprising because estrogens inhibit mitochondrial ROS
generation [51,52], although until now, there had been no con-
sensus regarding the participation of estrogen receptors in this
response [53]. In addition, for these animal models, the SOD activity
was increased as expected because the expression of this enzyme is
controlled by the presence of ROS, in particular H2O2 [54,55].
The observation that the treatment of hypertensive animals
with C. racemosa increased the mitochondrial ROS generation
L.B. Campos et al. / Free Radical Biology and Medicine 53 (2012) 680–689 687even more, however, was surprising, and this increase was not
accompanied by a proportional increase in SOD activity. SOD,
which facilitates the conversion of the superoxide anion (O2
) to
hydrogen peroxide, is the ﬁrst line of defense against mitochon-
drial ROS. Superoxide anions are highly unstable molecules and
cannot diffuse across biological membranes. Therefore, super-
oxide anions might accumulate in mitochondria and cause
oxidative damage, which initiates the formation of the mitochon-
drial permeability transition pores and leads to cellular death by
apoptosis or necrosis [56]. In fact, Lu¨de et al. [14] demonstrated
using in vitro and in vivo experiments that apoptosis and
alterations in mitochondrial morphology occur when using high
concentrations of C. racemosa, whereas Mazzanti et al. [57]
detected necrosis focused in the livers of rats that had been
treated with high doses of C. racemosa.
Additionally, the above results could in part explain why the
liver GSH content, which was reduced in the OVX and OVX þ
2K1C rats compared to the control rats, was not further reduced
in the treated, hypertensive rats, although the C. racemosa had
induced a higher mitochondrial ROS generation. That is, only the
H2O2 can diffuse to the cytosol where it is scavenged by the
GSH-Px enzyme, the major ROS scavenger, eliminating H2O2,
which escapes from mitochondria and peroxisomes by consuming
GSH [55].
Another factor that could contribute to the reduction of the
GSH content observed in OVX and OVX þ 2K1C rats was the
decreased activity of G6PD. It has long been known that this
enzyme is activated by estrogens [58]. This rate-limiting enzyme
of the pentose phosphate pathway is the major intracellular
source of NADPH, which serves as a cofactor for the GSSG-red
enzyme. Therefore, by restoring the GSH content, G6PD exerts a
critical role as a modulator of the cellular redox potential. In turn,
GSH is essential for the direct scavenging of ROS and for the
indirect scavenging of ROS by the GSH-Px enzyme. The restora-
tion of the G6PD activity in hypertensive OVX rats treated with
C. racemosa could be another factor contributing to the main-
tenance of the GSH contents of these animals, despite the
increased mitochondrial ROS generation.
Interestingly, the evaluation of the redox status of the livers
from these animals revealed that, in general, the hypertensive
phenotype in OVX rats did not produce additional and more
severe alterations in the cellular redox status. This result is not
surprising considering that 70% of the liver blood ﬂow is provided
by portal vein. Therefore, this organ must be less susceptible to
oxidative damage associated with hypertension, and the estrogen
deﬁciency seems to be the major contributor to the enhanced
oxidative stress in the liver [59–62].
The alterations observed in the liver of hypertensive, treated
rats are probably a consequence of representative adaptive
responses to the increased mitochondrial ROS generation and to
the reduction in the peroxisomal capacity to scavenge ROS as a
result of the decreased CAT activity induced by C. racemosa.
Despite the compensatory increase in the G6PD activity, some
oxidative damage had already occurred, as demonstrated by the
very high levels of TBARS in the livers of treated animals. The high
TBARS levels could be the result of the reduction in peroxisomal
CAT activity induced by C. racemosa that was not accompanied by
a proportional increase in the activity of GSH-Px, which is the
major cytosolic H2O2 scavenger. In addition, peroxisomal CAT
plays an important role as a H2O2 scavenger in the entire cell,
because this molecule can translocate across biological mem-
branes [50]. Although H2O2 is considered a stable molecule, it can
form hydroxyl radicals that initiate lipid peroxidation. In addition,
H2O2 can directly oxidize other cellular components [50,55].
It is important to stress that, as we expected, some hepatotoxic
effects of C. racemosa, which have been described only at toxicdosages by Lu¨de et al. (1000 mg/kg) [14] and Mazzanti et al.
(300 mg/kg) [57], could be observed at a much lower, therapeutic
dosage (0.6 mg/kg) of this plant, in our animal model. However,
our results differ from those of these authors in some features,
which deserve to be pointed out.
First, the main ﬁnding of Lu¨de and colleagues [14] was the
development of microvesicular steatosis in animals treated with high
dosages of C. racemosa. The authors attributed this phenomenon to an
inhibition of the mitochondrial b-oxidation by C. racemosa as a result
of a blockage in the respiratory chain, as demonstrated through
in vitro mitochondria experiments [14]. Although we were able to
reproduce these results in similar experiments, we could not detect
any alterations in the oxidative phosphorylation in mitochondria
isolated from treated animals (data not shown). Furthermore, if this
were the case, the mitochondrial b-oxidation should have been
inhibited, irrespective of the fatty acid presented. However, our
investigations revealed that only the mitochondrial (as well as
peroxisomal) oxidation of the medium-chain octanoyl-CoA was
inhibited by C. racemosa, suggesting a more speciﬁc inhibition,
probably encompassing enzymes involved in the transport and/or
in the oxidation of this fatty acid.
Mazzanti and colleagues, on the other hand, presented a more
remarkable result, the reduction in the GSH content in the livers
of male rats treated with C. racemosa (300 mg/kg) [57]. However,
it was demonstrated in our study that the liver GSH content was
not reduced by the treatment with C. racemosa. This discrepancy
could be the result of gender differences in the activity of the
enzyme G6PD. These sex differences were ﬁrst described by Ibim
et al. [58], who observed that the G6PD activity of female rats,
even castrated, is about 2.5-fold higher than that of intact male
rats. So, even if C. racemosa had exerted an estrogen-like effect,
the G6PD activity should have remained lower in male rats as
demonstrated for estradiol by Ibim et al. [58]. In addition, it has
been described that liver mitochondria from male rats produce
more peroxide than those of females [63].
These and other gender differences could make the livers of
male rats more susceptible to the toxic effects of C. racemosa, and
this could contribute to the lower levels of GSH found in male
animals treated with C. racemosa in the work of the team of
Mazzanti [57]. But this investigation was not the focus of the
authors. Another possibility that could explain the differences
observed in the liver GSH content in the current study and that
performed by Mazzanti and colleagues could be the much higher
doses employed by them [57].Conclusions
All of these ﬁndings increase the concerns regarding the safety
of ingesting C. racemosa by women suffering from other diseases
that could make the liver more susceptible to drug-induced
hepatotoxicity. For example, Lu¨de et al. [14] reported undesirable
effects of C. racemosa on liver fat disposal, which were manifested
only at toxic concentrations. In our model of hypertensive,
steatotic, and OVX rats, these effects could be observed at
concentrations similar to those recommended for postmenopau-
sal women. Furthermore, some effects not observed in this work
(e.g., the reduction in the GSH content) may occur after prolonged
treatments or with higher doses of C. racemosa.Acknowledgments
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